Introduction {#s1}
============

Lewy bodies (LB) and Lewy neurites (LN) are neuropathological hallmarks of Parkinson\'s disease and other Lewy body disorders. These intracellular neuronal features contain a cytoplasmic enrichment of the protein alpha-synuclein (α-Syn), thereby defining these diseases as synucleinopathies ([@bib79]; [@bib78]). Apart from this finding in the postmortem brain, the central role of α-Syn in Parkinson's disease (PD) is highlighted by the fact that certain mutations in the α-Syn gene (SNCA) cause familial forms of PD and other synucleinopathies ([@bib2]; [@bib42]; [@bib43]; [@bib63]; [@bib68]; [@bib89]) and that duplication or triplication of the SNCA gene lead to either a sporadic or early-onset PD, respectively, in affected families ([@bib7]; [@bib23]; [@bib24]; [@bib38]; [@bib77]). The 14 kDa protein α-Syn is known to readily form fibrils in vitro ([@bib11]; [@bib34]) and induce α-Syn inclusions when injected in model animals ([@bib60]; [@bib64]).

Shahmoradian et al. have recently investigated the ultrastructure of LBs, using identification by fluorescence light microscopy and then correlative imaging by electron microscopy (CLEM). They found that a slight minority of analyzed LBs contained filamentous or dense proteinaceous structures, while the vast majority of LBs was primarily composed of membrane fragments ([@bib45]; [@bib76]). However, even in those cases, LBs had been identified due to their enrichment of α-Syn (antibody LB509, recognizing residues 115--122 of α-Syn). [@bib59] recently studied the ultrastructure of LBs by super-resolution light microscopy, revealing an onion-like distribution of different forms of α-Syn in nigral LBs and LNs. Their work suggests LBs to be structured encapsulations of aggregated proteins and lipids. While the structure and building blocks of LBs and the putative involvement of aggregated forms of α-Syn in the formation of LBs or in toxicity towards neurons and glia appear to be more complex than previously thought, it is clear that the protein α-Syn plays a pivotal role in PD, and therefore in LB formation. The conformational state and impact of α-Syn protein may also differ strongly between synucleinopathies. [@bib65] reported α-Syn preparations from glial cytoplasmic inclusions from multiple system atrophy patients being much more potent in seeding α-Syn aggregation into cell cultures than α-Syn preparations than PD patients. A detailed understanding of the conformational space of structural polymorphs of α-Syn is important to move forward the discovery of diagnostic tools and therapeutics for synucleinopathies, including PD.

α-Syn protein consists of 140 amino acids. The N-terminus (residues 1--60) is rich in lysine residues and contains KTK lipid-binding motif repeats associated with vesicle binding ([@bib29]; [@bib28]; [@bib66]). It is also the region which contains all known SNCA familial PD mutations: A30P ([@bib42]), E46K ([@bib89]), H50Q ([@bib2]; [@bib71]), G51D ([@bib43]), A53E ([@bib63]), and A53T ([@bib68]). The central region (residues 61--95) is the non-amyloid-ß component (NAC region) ([@bib31]; [@bib83]), which is essential for α-Syn aggregation ([@bib46]). The related protein ß-synuclein (ß-syn) ([@bib40]; [@bib81]) lacks a stretch of 12 aminoacid residues within the NAC region (residues 71--82) and is unable to form fibrils.

The highly unstructured C-terminus of α-Syn (residues 96--140) can bind calcium and it is populated by negatively charged residues ([@bib48]; [@bib69]; [@bib85]). Truncation of this domain may play a role in α-Syn pathology by promoting fibril formation ([@bib12]; [@bib47]; [@bib51]; [@bib87]) and being involved in Lewy body formation ([@bib16]; [@bib54]; [@bib70]). Inhibition of C-terminal truncation has also been shown to reduce neurodegeneration in a transgenic mouse model of Multiple System Atrophy (MSA) ([@bib3]).

Amyloid fibrils, even within a single sample, may exhibit heterogeneous conformations, referred to as polymorphism. Different polymorphs can be distinguished based on their diameter, their twist, how many protofilaments form a fibril ([@bib72]), their behavior under limited proteolysis, their appearance under fiber diffraction ([@bib5]), or their structure using NMR or cryo- EM ([@bib8]; [@bib21]; [@bib58]). The polymorphs can be structurally different at the level of the protofibrils, or in the way the protofilaments assemble. Specifically for α-Syn fibrils, structural heterogeneity has been observed by solid-state NMR ([@bib5]; [@bib10]; [@bib9]; [@bib25]; [@bib26]; [@bib27]; [@bib36]; [@bib53]; [@bib84]; [@bib85]), quenched hydrogen/deuterium (H/D) exchange data ([@bib85]) and cryo-EM ([@bib33]; [@bib49]; [@bib50]). A detailed understanding of the conformational space that structural polymorphs of α-Syn do access is central to not only understand how the same polypeptide chain can fold into different structures, but also to thoroughly characterize materials used for in vitro and in vivo experiments.

Our recent work on the structure of recombinant α-Syn(1-121), using cryo-electron microscopy (cryo-EM) ([@bib33]) and other investigations on full-length α-Syn ([@bib49]; [@bib50]) revealed α-Syn fibrils in a structure composed of two protofilaments that buried the sites associated with familial PD in the interface region between the two protofilaments. This is here termed α-Syn polymorph 1a. Li et al. ([@bib49]) reported an additional polymorph, here termed α-Syn polymorph 1b, in which the interface between virtually identical protofilaments is different. Previous reports on the structure of α-Syn fibrils by micro-electron diffraction (microED; [@bib73]) or solid-state NMR ([@bib82]) either focused on small peptides, or did not describe the two protofilaments and the interface region.

Currently, no high-resolution structures of patient derived α-Syn have been obtained. Previous studies looking at the overall morphology of these types of samples, offered a first glance to fibril variability within a sample and among synucleinopathies. Filaments immunolabeled by α-Syn antibodies have been described as straight, unbranched fibrils, with widths of 5 nm or 10 nm and with varying patterns of conjugated gold depending on the specific antibody used ([@bib13]). Filaments extracted from cingulate cortex of patients with Dementia with Lewy Bodies (DLB) were also positive for α-Syn immunolabeling and revealed comparable morphologies ([@bib79]). In contrast, filaments extracted from Multiple System Atrophy (MSA) brains exhibited larger diameter spanning from 5 nm to 18 nm with two morphologies described by Spillantini et al. ([@bib80]) as 'straight\'\' and 'twisted'.

Here, we report new cryo-EM polymorphic structures of in vitro generated amyloid fibrils of α-Syn (denoted polymorphs 2a and 2b). Our structures reveal remarkable differences to the previously solved α-Syn polymorphs, and inform new hypotheses to explain the mechanism of and factors involved in in vitro amyloid fibril assembly, the potential role of familial PD mutations on fibril structure, and contribute to our understanding of amyloid fibril polymorphism.

Results and discussion {#s2}
======================

The structure of α-Syn fibril polymorphs {#s2-1}
----------------------------------------

Fibrils of recombinant, full-length, human α-Syn were prepared using the conditions summarized in [Table 1](#table1){ref-type="table"}. Preformed fibrils (PFFs) were quick-frozen in holey carbon-coated copper grids and imaged with a Titan Krios electron microscope at 300kV, equipped with a Quantum-LS energy filter. Micrographs were acquired with a K2 Summit direct electron detector, drift-corrected and dose-weighted through the FOCUS interface ([@bib4]).

###### Growth conditions for α-Syn fibrils.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study         Buffer composition                      pH                Temp--erature        Time                      Concen--tration   Method                    α-Syn type                            Poly--morph           PDB
  ------------- --------------------------------------- ----------------- -------------------- ------------------------- ----------------- ------------------------- ------------------------------------- --------------------- -------
  This study    50 mM Tris-HCl\                         7.5               37°C                 1 week (600 r.p.m.)       700 µM            Cryo-EM + NMR             Full-length ('named fibrils')         2a, 2b                6ssx\
                150 mM KCl                                                                                                                                                                                                       6sst

  ([@bib33])    DPBS (Gibco)\                           7 to 7.3          37°C                 5 days (1000 r.p.m.)      360 µM\           Cryo-EM                   Truncated\                            1a                    6h6b
                2.66 mM KCl,\                                                                                            (5 mg/mL)                                   (1-121)                                                     
                1.47 mM KH2PO4,\                                                                                                                                                                                                 
                137.93 mM NaCl, 8.06 mM Na2HPO4                                                                                                                                                                                  

  ([@bib49])    50 mM Tris, 150 mM KCl,\                7.5               37°C                 3 days (900 r.p.m.)       500 µM            Cryo-EM                   Full-length,\                         1a                    6a6b
                0.05% NaN3                                                                                                                                           N-terminal acetylated                                       

  ([@bib50])    15 mM tetrabutyl--phosphonium bromide   Not speci--fied   Room tempe--rature   14--30 days (quiescent)   300 µM            Cryo-EM                   Full-length                           1a,b                  6cu7\
                                                                                                                                                                                                                                 6cu8

  ([@bib82])    50 mM sodium phosphate\                 7.4               37°C                 3 weeks (200 r.p.m.)      1000 µM\          NMR                       Full-length                           1a                    2n0a
                0.12 mM EDTA\                                                                                            (15 mg/mL)                                                                                              
                0.02% sodium azide (w/v)                                                                                                                                                                                         

  ([@bib73])    5 mM lithium hydroxide\                 7.5               37°C                 72 hr                     500 µM            Micro-ED                  Peptides: SubNACore, NACore, PreNAC                         4rik\
                20 mM sodium phosphate\                                                                                                                                                                                          4ril\
                0.1 M NaCl                                                                                                                                                                                                       4znn

  ([@bib73])    50 mM Tris\                             7.5               37°C                 72 hr                     500 µM            No structure              Full-length                                                 
                150 mM KCl                                                                                                                                                                                                       

  ([@bib26])    50 mM Tris-HCl\                         7.5               37°C                 4 days (600 r.p.m.)       300 µM            NMR secondary structure   Full-length                           2                     
                150 mM KCl                                                                                                                                                                                                       

  ([@bib25])    5 mM Tris-HCl                           7.5               37°C                 7 days (600 r.p.m.)       300 µM            NMR secondary structure   Full-length                           Different from 1, 2   

  ([@bib84])    5 mM NaPO4                              9                 37°C                 4 days (600 r.p.m.)       300 µM            NMR secondary structure   Full-length                           1                     

  This study    DPBS (Gibco):\                          7 to 7.3          37°C                 5 days (1000 r.p.m.)      360 µM\           Cryo-EM                   Full-length, E46K                     2a                    
                2.66 mM KCl,\                                                                                            (5 mg/mL)                                                                                               
                1.47 mM KH2PO4,\                                                                                                                                                                                                 
                137.93 mM NaCl, 8.06 mM Na2HPO4                                                                                                                                                                                  

  This study    DPBS (Gibco):\                          7 to 7.3          37°C                 5 days (1000 r.p.m.)      360 µM\           Cryo-EM                   Full-length,\                         2a                    
                2.66 mM KCl,\                                                                                            (5 mg/mL)                                   N-terminal acetylated                                       
                1.47 mM KH2PO4,\                                                                                                                                                                                                 
                137.93 mM NaCl, 8.06 mM Na2HPO4                                                                                                                                                                                  

   This study   DPBS (Gibco):\                          7 to 7.3          37°C                 5 days (1000 r.p.m.)      360 µM\           Cryo-EM                   Full-length,\                         2a                    
                2.66 mM KCl,\                                                                                            (5 mg/mL)                                   Phosphorylation at position S129                            
                1.47 mM KH2PO4,\                                                                                                                                                                                                 
                137.93 mM NaCl, 8.06 mM Na2HPO4                                                                                                                                                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Helical image processing of 100'323 fibril segments extracted from 1'143 micrographs, revealed the presence of two distinct fibril polymorphs at the step of 3D classification. These polymorphs, termed α-Syn polymorph 2a and α-Syn polymorph 2b to distinguish them from the previously described α-Syn fibrils (α-Syn polymorphs 1a and 1b; [@bib33]; [@bib49]; [@bib50]), were separately refined, resulting in 3D reconstructions at overall resolutions of 3.0 Å and 3.4 Å respectively ([Table 2](#table2){ref-type="table"}, [Table 3](#table3){ref-type="table"}, [Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"} and [Video 1](#video1){ref-type="video"}). The left-twisting handedness of the fibrils was confirmed by AFM imaging, as done previously ([@bib33]). The maps show clear side-chain densities and ß-strand separation along the helical axis, and indicate that both fibril types are formed by two protofilaments of approximately 5 nm diameter, which are composed of distinct rungs of density.

![Cross-sections of the α-Syn polymorph 2a and 2b cryo-EM structures.\
(**A**) Sequence of human α-Syn with familial PD mutation sites indicated in red. ß strands are indicated by arrows colored from blue to orange. Cryo-EM densities and atomic models of polymorph 2a (**B**) and polymorph 2b (**C**) of α-Syn. Each cryo-EM map shows two protofilaments (blue and orange) forming a fibril. PD-associated mutations sites, and first and last residues of the NAC regions are indicated. (**D** and **E**) Rainbow rendering views of the secondary structure elements in five successive rungs of both polymorphs. A view perpendicular to the helical axis is shown to illustrate the height differences in a single α-Syn fibril. Colors correspond to the arrows in the sequence displayed in panel (**A**).](elife-48907-fig1){#fig1}

###### Cryo-EM structure determination statistics.

                                               E46K mutant    Phosphorylated   N-terminal acetylated   α-Syn polymorph 2a   α-Syn polymorph 2b
  -------------------------------------------- -------------- ---------------- ----------------------- -------------------- --------------------
  Data Collection                                                                                                           
  Pixel size \[Å\]                             0.831          0.831            0.831                   0.629                0.629
  Defocus Range \[µm\]                         −0.8 to −2.5   −0.8 to −2.5     −0.8 to −2.5            −0.8 to −2.5         −0.8 to −2.5
  Voltage \[kV\]                               300            300              300                     300                  300
  Exposure time \[s per frame\]                0.2            0.2              0.2                     0.2                  0.2
  Number of frames                             50             50               50                      50                   50
  Total dose \[e^-^/Å^2^\]                     69             69               69                      69                   69
  Reconstruction                                                                                                            
  Box width \[pixels\]                         280            280              280                     280                  280
  Inter-box distance \[pixels\]                28             28               28                      28                   28
  Micrographs                                  843            1'887            948                     1'143                1'143
  Manually picked fibrils                      2'702          5'095            3'751                   5'233                5'233
  Initially extracted segments                 65'893         107'144          43'276                  100'323              100'323
  Segments after 2D classification             50'514         107'126          35342                   100'193              100'193
  Segments after 3D classification             50'514         21'685           35342                   19'937               3'989
  Resolution after 3D refinement \[Å\]         4.65           4.65             4.75                    3.34                 3.75
  Final resolution \[Å\]                       4.56           4.31             4.39                    2.99                 3.39
  Estimated map sharpening B-factor \[Å^2^\]   −208.6         −104.3           −178.1                  −67.1                −76.4
  Helical rise \[Å\]                           4.85           4.84             4.78                    4.80                 2.40
  Helical twist \[°\]                          −0.79          −0.77            −0.71                   −0.80                179.55

###### Model building statistics.

  --------------------------------------------------------------------------------------
                                               α-Syn polymorph 2a   α-Syn polymorph 2b
  -------------------------------------------- -------------------- --------------------
  Initial model used \[PDB code\]              6ssx                 6sst

  Model resolution \[Å\]\                      2.98                 3.4
  (FSC = 0.143)                                                     

  Model resolution range \[Å\]                 2.98                 3.1

  Map sharpening *B*-factor \[Å^2^\]           −67.1                −76.4

  Model composition\                           4900\                4900\
  Non-hydrogen atoms\                          730\                 730\
  Protein residues\                            0                    0
  Ligands                                                           

  *B*-factors \[Å^2^\] (non-hydrogen atoms)\   48.18\               70.32\
  Protein\                                     -                    -
  Ligand                                                            

  R.m.s. deviations\                           0.008\               0.009\
  Bond lengths \[Å\]\                          0.938                0.941
  Bond angles \[°\]                                                 

  Validation\                                  2.43\                2.11\
  MolProbity score\                            6.14\                5.73\
  Clashscore\                                  4.26                 2.13
  Poor rotamers \[%\]                                               

  Ramachandran plot\                           87.39\               89.86\
  Favored \[%\]\                               12.61\               10.14\
  Allowed \[%\]\                               0.00                 0.00
  Disallowed \[%\]                                                  
  --------------------------------------------------------------------------------------

###### Comparison of cryo-EM maps of α-Syn fibril polymorphs.

Cryo-EM reconstructions of α-Syn fibrils at 3.0 Å (polymorph 2a) and 3.4 Å (polymorph 2b) resolution detailing the interaction between two protofilaments (blue and orange) in each fibril, the 4.8 Å spacing between ß-strands and the topology of α-Syn monomers within a single protofilament.

Refined atomic models of the fibril cores indicate that polymorph 2a and polymorph 2b in terms of their local atomic structure share a common protofilament kernel, and which is clearly distinct from the one described previously in polymorphs 1a and 1b. However, the packing between the two protofilaments is different. Therefore, α-Syn fibrils exhibit assembly polymorphism as defined by [@bib72] and described in Tau between paired helical filaments (PHFs) and straight filaments (SFs) ([@bib22]). In each protofilament of the new α-Syn polymorph 2a, successive rungs of ß-strands are related by helical symmetry with a rise of 4.8 Å and a twist of −0.80° with the subunits within the two protofilaments packed in the same plane, facing each other ([Figure 1D](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2C](#fig1s2){ref-type="fig"}) in two-fold symmetry. Distinctively, the two protofilaments in α-Syn polymorph 2b are offset by 2.4 Å in height between each other, related by an approximate 2~1~ screw symmetry with a twist of 179.55° ([Figure 1E](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}). In α-Syn polymorph 2a, residue K45 of one protofilament forms a salt-bridge with residue E57 of the other protofilament, and vice-versa ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). In α-Syn polymorph 2b, the interaction between protofilaments occurs only through salt-bridges between residues K45 and E46 from adjacent protofilaments ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}).

For polymorph 2a (PDB ID 6SSX) and polymorph 2b (PDB ID 6SST), each α-Syn molecule within a protofilament is composed of eight in-register parallel ß-strands (ß0--7; [Figure 1A,D and E](#fig1){ref-type="fig"}): residues 16--20 (ß0), 38--44 (ß1), 46--50 (ß2), 52--56 (ß3), 61--66 (ß4), 68--72 (ß5), 76--79 (ß6), and 85--92 (ß7). These are separated by either a lysine (L45) between ß1 and ß2, glycine residues (that is, G51 between ß2 and ß3, and G67 between ß4 and ß5) or arches (that is, E57-K60 between ß3 and ß4, G73-T75 between ß5 and ß6, and K80-G84 between ß6 and ß7). The NAC region encompasses ß-strands ß4 to ß7 and it appears entirely surrounded by densities in our cryo-EM map with ß1 to ß3 on one side of the fibril and additional densities on the other side. Minor differences between polymorphs 2a and 2b are observed in the turn between ß3 and ß4 ([Figure 1D and E](#fig1){ref-type="fig"}, [Figure 2A and C](#fig2){ref-type="fig"}).

![Structure and distribution of amino acids in the new α-Syn fibril polymorphs.\
Amino acids are colored in blue for positively charged, in red for negatively charged, in green for polar (including glycine), and in white for hydrophobic residues. Even and odd numberings are given on one monomer each. (**A** and **C**) Backbone structure. (**B**) and (**D**) Surface view.](elife-48907-fig2){#fig2}

As described for α-Syn polymorph 1a ([@bib33]), and also shown in patient-derived Tau filaments ([@bib22]), there are considerable changes in the height of the α-Syn monomer along the helical axis, with the highest point being ß3 and the lowest ß4 ([Figure 1D and E](#fig1){ref-type="fig"}).

α-Syn fibrils in polymorph 1a are formed by ß-stands that are arranged in bent β-arches, running along the length of each protofilament, previously described as a Greek key-like architecture ([@bib33]; [@bib49]; [@bib50]; [@bib82]). Also, the polymorphs 2a and 2b reported here present bent β-arch motifs. However, the components and the orientation of ß-strands contributing to the motifs are now radically different. In polymorphs 2a and 2b, two bent β-arches orient back-to-back, one showing a single, and the other showing two bends. The first β-arch is formed by strands 1/6, 2/5 and 3/4, with bends located at residues K45/V74, G51/G67, and the tip formed by K58. The strands interact through mainly hydrophobic, but also polar clusters. The second bent β-arch shares β-strands 4, 5 and 6 with the first one, and comprises in addition β-strand 7; again, interactions within the arch are of hydrophobic and polar type. This arch shows only one bend, at residues G67/G84.

The structure shares the extended use of glycine residues to form turns, and the hydrophobic and polar clusters forming the fibril core with other fibril structures (as for instance amyloid-β; [@bib32]; [@bib75]; [@bib86]), which contribute to protofilament stability, as also previously shown for α-Syn polymorph 1a ([@bib33]; [@bib49]; [@bib50]).

Similar to α-Syn polymorph 1a, hydrophilic clusters are found at the periphery of the fibril ([Figure 2](#fig2){ref-type="fig"}). However, in contrast to α-Syn polymorph 1a, where the protofilament interface is formed by a hydrophobic steric-zipper geometry, in polymorphs 2a and 2b the interface is formed by salt bridges.

Interestingly, residue I88 marks the beginning of a hydrophobic area composed of residues A89, A90, A91, F94 and V95, which contribute to the stabilization of an additional beta-strand density that is clearly visible in the cryo-EM maps of both polymorphs ([Figure 1B and C](#fig1){ref-type="fig"}). We propose that this interacting region corresponds in polymorph 2a to a hydrophobic stretch formed by residues V16 to E20, and here use for it the term β0. This region was previously shown to be an isolated ß-strand identified in the N-terminus of α-Syn fibrils by solid-state NMR on equivalent fibril preparations ([@bib5]; [@bib26]) ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}). The localization of the stretch can be derived from cross peaks present in NMR 2D PAR ([@bib14]) spectra that connect S87 to A17, A18 and A19 ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}). Cross peaks in PAR spectra are indicative of proximities smaller than 6--7 Å between the spins, as illustrated in [Figure 1---figure supplement 3D](#fig1s3){ref-type="fig"}, which shows other meaningful structural restraints identified. This localizes A17, A18 and A19 in proximity to S87 ([Figure 1---figure supplement 3C](#fig1s3){ref-type="fig"}). The orientation of the N-terminal β0-strand is then given by both the absence in the spectra of cross peaks between S87 and V16, as well as clear side chain density fitting K21 in the EM map. Interestingly, no signals were observed in the NMR spectra for residues M1-V15, K21-V37 and V95-A140 in the α-Syn fibril structure. These regions correspond precisely to the stretches in our cryo-EM structure for which model building is not possible due to lower resolution, suggesting that these regions are indeed disordered in this polymorph. Also, no NMR peak doubling, although present for a subset of resonances ([@bib26]), was observed for residues at the filament interface, and no distinction could be made between polymorphs 2a and 2b, indicating that the structures of the monomers in the polymorphs 2a and 2b are very close to each other. The interruption of the polypeptide chain between strands ß0 and ß1 in polymorph 2a and 2b due to lack of clear density is compatible with a connection to the following strands of the same layer or alternatively to the neighboring layer.

For both α-Syn polymorph 2a and 2b, differences in height within residues of a protofilament reveal a hydrophobic area ([Figure 2](#fig2){ref-type="fig"}) akin to the hydrophobic cleft described for α-Syn polymorph 1a ([@bib33]). It is composed of residues Q62 to V74 (ß4-ß5) ([Figure 1D and E](#fig1){ref-type="fig"}), and located between ß-strands ß2/ß3 and ß6/ß7. These residues correspond to a stretch of exclusively hydrophobic or polar residues, completely devoid of charged amino acids. Consistent with these results and with the concept that the hydrophobic core is essential for assembly, is the finding by [@bib17] that, within the NAC region, residues E61-A78 are the amyloidogenic component. The hydrophobic cleft in α-Syn polymorphs 2a and 2b contrasts with the one found in α-Syn polymorph 1a, where intermolecular interactions involving residues V74-V82 may be the initial binding event responsible for fibril elongation ([@bib33]).

Our structural cryo-EM analysis of α-Syn fibrils prepared with E46K mutant or phosphorylated and N-terminally acetylated protein shows these also to be composed of two protofilaments and having an overall diameter of 10 nm ([Figure 3](#fig3){ref-type="fig"}). The lower order of these fibrils prevented a separation of the α-Syn rungs along the fibril axis, but still allowed discerning the separation of individual ß-sheets. As with polymorphs 1a, 2a and 2b, ß-sheets in α-Syn fibrils from E46K mutant, phosphorylated or N-terminally acetylated protein are arranged forming the characteristic bent β-arch like shape, and an arrangement closely resembling that of polymorph 2a ([Figure 3](#fig3){ref-type="fig"}).

![Cryo-EM cross-sections of fibrils, formed by E46K, p-S129 phosphorylated, and N-terminally acetylated α-Syn protein.\
Fibrils formed by E46K mutant α-Syn protein (**A**), Ser129 phosphorylated α-Syn protein (**B**), and N-terminally acetylated α-Syn protein (**C**) were analyzed by cryo-EM. Image processing did not allow reaching sufficient resolution for model building, but the cross-sections of the obtained 3D reconstructions are compatible with polymorph 2a for all three forms.](elife-48907-fig3){#fig3}

Comparison with previous structures {#s2-2}
-----------------------------------

At first glance, the back-to-back arranged β-arches of polymorphs 2a and 2b appear similar to that of polymorph 1a, wrongly proposing that a mere protofilament rearrangement defines the difference between them. However, closer inspection and comparison with secondary structure elements identified in previous NMR studies on equivalent fibril preparations ([@bib5]; [@bib26]) revealed that polymorphs 2a and 2b radically differ from the construction of polymorphs 1. [Figure 4](#fig4){ref-type="fig"} shows the backbones of the polymorphs with different color codes for N-terminus, NAC region, and C-terminus, and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} shows each 10 residues in a different color. When compared to polymorphs 1, the new structures of polymorphs 2a and 2b show an inverted bend of the first β-arch motif, comprising mainly the black and cyan segments in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. This motif is largely conserved between polymorphs 1a and 1b ([@bib49]) ([Figure 4](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"} and [Video 2](#video2){ref-type="video"}), where it forms part of the interfilament interface, once via the black segment in polymorph 1a, and once via the cyan/light green segments in polymorph 1b. In polymorphs 2, this β-arch is formed by an inverted amino-acid sequence: when the two motifs are superimposed, the chain runs from cyan to black in one case, in the other from black to cyan. This inversion profoundly changes the amino acid distribution within the arch between polymorphs 1 and 2. Also, the β-arch in polymorph two is extended with a second bend followed by a β-strand region, comprising part of the orange segment largely unobserved in polymorphs 1.

![Schematic representation of α-Syn polymorphs.\
(**A**) Diagram representing α-Syn regions with the N-terminus in blue, the NAC region in red and the C-terminus in yellow. (**B**) Representation of α-Syn fibril polymorphs 1a (PDB ID 6h6b; [@bib33]), 1b (PDB ID 6cu8; [@bib49]), 2a (PDB ID 6rt0, this work), and 2b (PDB ID 6rtb, this work), highlighting the striking differences in protofilament folding in α-Syn polymorphs 1a and 1b, compared to α-Syn polymorphs 2a and 2b. The atomic models obtained by cryo-EM of α-Syn polymorph 1a, polymorph 1b ([@bib49]; [@bib50]) and α-Syn polymorphs 2a and 2b (this work). Protein Data Bank (PDB) accession numbers are indicated.](elife-48907-fig4){#fig4}

###### Structural differences between α-Syn polymorphs.

Atomic models of α-Syn fibrils represented as rounded ribbons with the N-terminus in blue and the NAC region in red.

In polymorphs 1, the light green chain segment form, together with parts of the above-described first β-arch, a second bent β-arch, completed by the red segment. This motif again exists in polymorphs 2, but is located on the outside of the first arch, while in polymorph 1a it is located at the inside. Also, the arch is inverted, and the amino acid distribution again differs, as shown by the different arrangement of the colored segments. Polymorph 1b is devoid of this motif. A hydrophilic cavity identified in polymorph 1a (located in the bend between the black and light green segments) is also present in polymorphs 2, but there between the partly disordered pink/orange segments, and the red segment.

The different arrangements result in a radically changed interface between the protofilaments in polymorphs 1 and 2. Unlike the hydrophobic interaction between protofilaments in polymorph 1a by the black segment, and in 1b by the cyan and light green segments, the interface in the new polymorphs 2a and 2b is formed by electrostatic interactions in the green segment, through salt-bridges between residues K45 and E57, or K45 and E46, respectively in 2a and 2b polymorphs ([Figure 1---figure supplement 2C and F](#fig1s2){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}, [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}).

Furthermore, the presence of an additional ß-strand ß0 on the periphery of the fibril (in the blue segment) is a remarkable difference between polymorphs 1 and polymorphs 2. This stretch of residues, V16-E20, forms a hydrophobic steric-zipper geometry with residues S87-A91, which are part of ß7, at the end of the amyloidogenic NAC region. In polymorphs 2a and 2b, this results in the N-terminus wrapping around the fibril and enclosing the NAC region (cyan, light green and red segments). This buries the serine residue at position 87, a phosphorylation site located within the NAC region, inside this interface. This is in contrast to α-Syn polymorph 1a, where approximately 40 residues on both ends of the α-Syn fibril are flexible and surround the fibril with a fuzzy coat, leaving part of the NAC region (that is, K80 to V95, red and magenta segments), including S87, exposed ([Figure 1B and C](#fig1){ref-type="fig"}, [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}).

Origin of distinct α-Syn polymorphs {#s2-3}
-----------------------------------

Presently, there are four different polymorphs of α-Syn fibrils known at atomic resolution, including the structures presented here. They can be classified into two groups with each group having a distinct fold (folds 1 and 2) (that is, at the protofilament level). Within each group there are two distinct protofilament packings or assembly polymorphisms (polymorphs a and b; [Figure 4](#fig4){ref-type="fig"}).

In an attempt to rationalize the origin of the distinct polymorphs, we first concentrate on the distinct folds at the protofilament level. All fold one structures (polymorphs 1a and 1b) were grown under buffer conditions comprising either a poly-anion (that is, phosphate with three negative charges and N~3~^-^ with having locally two negative charges) or a big chaotropic negative ion (that is Br^-^), while polymorphs 2a and 2b of wildtype α-Syn were grown under phosphate-free conditions with the only anion being Cl^-^ ([Table 1](#table1){ref-type="table"}). Interestingly, there are adjacent to the salt-bridge H50-E57 three lysine residues in polymorph 1a at positions K43, K45 and K58 (the latter from the other protofilament) that are close in space. Between them, [@bib33] observed a density in the cryo-EM map, presumably a phosphate ion of poly-anionic nature that neutralizes the repulsion of the three positive charged residues ([Figure 4](#fig4){ref-type="fig"}). Albeit still of polymorph 1a type, in the presence of N~3~^-^ the structure is distinct in this area with K58 flipping inward into the cavity forming a salt-bridge with E61 attributed to the less poly-anion-like character of N~3~^-^ when compared with phosphate. In the presence of the chaotropic Br^-^, K58 is facing more the solvent with a closer distance between H50 and K45 ([Figure 4](#fig4){ref-type="fig"}). In the absence of a neutralizing poly-anion in this area of positively charged side chains or Br^-^ exerting its chaotropic property, it is unlikely that polymorph one can be obtained, indicating that in the presence of Cl^-^ as the only anion, a distinct polymorph must be formed.

The fibrils of the familial variant E46K ([Figure 3](#fig3){ref-type="fig"}) were also grown under phosphate conditions but adopt polymorph 2a fold. The polymorph 1a fold we obtained for the wildtype 1--121 form, introduces an electrostatic repulsion between K46 and K80, instead of the 46--80 salt-bridge stabilizing this polymorph. The structural features thus provide a rationale how changes corresponding to only a few kcal (or less) in the stability of polymorph 1a (such as absence/presence of phosphate, single point mutation), can lead to the protein adopting an entirely different polymorph. This finding also highlights the postulated flat energy landscape of fibril formation and the conformational promiscuity that comes along with it.

The fact that the polymorphs found both by Li et al. ([@bib49]) and here by us are distinct, further accentuates this remark as they grew under similar conditions (except for the salt composition and additives, see [Table 1](#table1){ref-type="table"}). While the packing interfaces between polymorphs 1a and 1b are both hydrophobic, they still substantially differ, as in polymorph 1a residues V66-A78 form the interface, and in polymorph 1b residues H50-E57 form the interface ([Figure 4](#fig4){ref-type="fig"}). The difference is smaller in the case of polymorphs 2, where the protofilament interactions are of inter-protofilament salt-bridge character but are packed differently. It is evident that the energy differences between the two polymorphs are therefore very minute, but still the structures are distinct.

Familial PD mutation sites in the new α-Syn polymorphs {#s2-4}
------------------------------------------------------

A series of familial mutations have been identified in families with a history of PD. Based on [@bib24] and [@bib23], these mutations may lead to sporadic PD (A30P, E46K, A53E), early-onset (G51D, A53T) or late-onset (H50Q) forms of Parkinson's disease. The localization of the different sites in the structures is compared in [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}. Fundamentally different folds between polymorphs 1 and 2 place the familial PD mutation sites into an entirely different environment.

The E46K mutation has been found to promote α-Syn phosphorylation in mice ([@bib15]), and in neuronal cells it showed to be toxic, with toxicity being enhanced by simultaneously mutating E35 and E61 to lysines ([@bib57]). E46 holds a central role in polymorphs 1a and 2b. In polymorph 1a, where this motif resides at the beginning of one bent β-arch, E46 forms a stabilizing salt-bridge with K80. In contrast, in α-Syn polymorph 2b this residue is part of the protofilament interface, where the K45-E46 salt-bridge interface to E46-K45 from the other protofibril appears to be critical to the protofilament interface as these residues are the only interaction point between the protofilaments ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Thus, protofilament interaction in this polymorph 2b manner would be unlikely since the mutation would induce a charge repulsion between lysines K45 and E46K from the two protofilaments. And indeed, the mutant E46K adopts polymorph 2a, which result in two lysines (that is, K45 and K46) from one protofilament interacting with E57 in the other. Interestingly, the α-Syn E46K mutant fibril investigated here by cryo-EM, resulted in protofilament assembly corresponding to α-Syn polymorph 2a, confirming that the interaction between K45/K46 and E57 can indeed be maintained ([Figure 3](#fig3){ref-type="fig"}).

Heterozygous mutations in residues H50, G51, and A53 are associated with familial forms of PD ([@bib2]; [@bib43]; [@bib63]; [@bib68]). As we reported previously, in α-Syn polymorph 1a, these sites are an integral part of the interface region, contributing to the steric-zipper architecture and fibril stability, so that the mutations G51D, A53E and A53T are not compatible with polymorph 1a ([@bib33]) ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In contrast, in α-Syn polymorph 2a, these residues lie in the cavity formed between the two protofilaments, and in polymorph 2b they are surface-exposed where the two protofilaments interact ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). While these mutations are not in direct conflict with the formation of α-Syn fibril polymorphs 2a and 2b, the structures of fibrils formed with these mutations remain to be determined.

The A30P mutation leads to a form of PD with an age of onset between 54 and 76 years ([@bib23]; [@bib24]; [@bib42]). In our structures of polymorphs 2a and 2b, a steric-zipper interface between V16-E20 and I88-A91 causes the α-Syn N-terminus to wrap around the NAC region. Under these conditions, residue A30 might be surface-exposed in a defined manner, as it forms part of the fibrillar core in the sense that it is on both sides linked to nearby structured regions. The disordered nature of the region between K21 and G37 results in weak density in the cryo-EM map, and makes accurate model building in this region difficult. Nevertheless, in α-Syn polymorph 1a, A30 is not part of the fibril core but instead is found in the disordered region corresponding to residues M1 to V37 ([@bib33]).

Post translational modifications (PTMs) and fibrillization in α-Syn polymorphs {#s2-5}
------------------------------------------------------------------------------

Certain post-translational modifications of α-Syn associated with neuropathology inhibit the process of α-Syn fibril formation in vitro, suggesting that they are late events rather than occurring before protein aggregation ([@bib62]). Most of these modifications take place at the C-terminal region ([@bib54]), with the exception of acetylation and ubiquitination, which mostly affect residues in the N-terminal region. Ubiquitination alters mostly N-terminal lysines between residues 1 and 36, with K21, K23, K32 and K34 being the major sites for ubiquitin conjugation ([@bib61]). The phosphorylated and acetylated forms determined here fold into polymorph 2a ([Figure 3](#fig3){ref-type="fig"}). In this polymorph, the amino-acid stretch, which appears disordered in polymorph 1a fibrils, is more distinct, as the interaction of ß-strand ß0 with the fibril core brings the N-terminal region back to the fibril. While the involvement of the N-terminal region has been suggested by NMR for two different polymorphs ([@bib5]; [@bib25]; [@bib26]; [@bib27]), our structure for the first time shows how this N-terminal region that is important in the context of post-translational modifications, can be positioned in the protofilament.

Implications for fibril preparation protocols {#s2-6}
---------------------------------------------

When pre-formed fibrils (PFFs) are to be studied, the protocol used for their preparation is crucial. Conditions used to prepare such samples vary ([Table 1](#table1){ref-type="table"}). It has been previously shown that α-Syn polymorphism may arise when different fibrillization methods are used ([@bib53]; [@bib84]). NMR has shown to be able to distinguish fibrils in polymorphic mixtures in samples, when the monomer fold differs substantially ([@bib5]; [@bib25]; [@bib26]; [@bib27]; [@bib84]). Still, NMR could for instance not distinguish between the two assembly polymorphs 2a and 2b. The here reported fibril polymorphism raises questions regarding the structural consistency of recombinant fibrils generated to study α-syn in vitro and calls to investigate the structures resulting from different fibril preparation conditions, or to screen fibril polymorphism in samples prepared by a single preparation protocol, in order to compile a library of α-Syn polymorphs to inform studies using PFFs on cell culture or animal models.

Recently, fibrillar aggregates of Tau protein were purified from human postmortem brain from Alzheimer\'s, Pick\'s disease, and chronic traumatic encephalopathy patients, showing variations in Tau fibril conformations between diseases ([@bib19]; [@bib20]; [@bib22]), and these fibrils all differed from the in-vitro generated, heparin-induced tau fibrils ([@bib90]). However, to our knowledge, purification of α-Syn fibrils from human brain of Parkinson\'s disease patients is more challenging. Existing protocols so far have only been able to produce filamentous material that co-fractionated with numerous contaminants (*e.g.*, lipofuscin, amyloid, etc.), including membranes ([@bib39]). Light microscopy and electron microscopy approaches to analyze the ultrastructural composition of LBs show location maps by fluorescence or structural features at the nanometer scale ([@bib45]; [@bib59]; [@bib76]). But methods to study the presence and polymorph of α-Syn fibrils in the diseased human brain and cerebrospinal fluid, and the mechanisms by which α-Syn may be causing Parkinson\'s disease and contribute to progression of the disease, remain to be developed.

Conclusion {#s2-7}
----------

We present here two new structures of α-Syn fibril polymorphs (polymorph 2a (PDB ID 6ssx), and polymorph 2b (PDB ID 6sst)). These differ in their protofilament interfaces but are formed by the same protofibril subunit structure, which is distinct from previously described α-Syn folds.

Our results describe 3D structures very different from previous work and demonstrate how α-Syn amyloid fibrils can reach different cross-ß architectures in spite of having the same amino acid sequence. The structural information from the various α-Syn polymorphs allowed informed hypotheses on how amyloid fibrils may form and how their formation may be related to pathogenicity. More importantly, these structures add to the knowledge of the conformational space of this protein, which is central for structure-based design of imaging tracers or inhibitors of amyloid formation. In this context, a large scale, in vitro study, investigating the structure of α-Syn fibrils produced under different aggregation conditions would prove very informative.

Determination of the structural space of fibril polymorphs, including those of α-Syn carrying disease-relevant mutations, and of α-Syn states purified from diseased human brain, is pivotal to discover whether and how fibrils might form or could be dissolved, and if and how they may interact with affected neurons and contribute to disease.

Materials and methods {#s3}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                           Designation                Source or reference             Identifiers                                               Additional\
  (species) or resource                                                                                                                                        information
  --------------------------------------- -------------------------- ------------------------------- --------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------
  Strain, strain background (*E. coli*)   BL21(DE3)                  Stratagene                      Agilent Technology \#200131                               Expression performed in LB medium

  Transfected construct (pET-3a)          pET3a                      Novagen                         <https://www.addgene.org/vector-database/2637/>           Encoding full length human alpha synuclein asyn (UniProtKB - P37840) with a silent mutagenesis of codon 136 (TAC to TAT)

  Transfected construct (pRT21)           pRT21                      ([@bib56])                                                                                Full length human alpha synuclein asyn (UniProtKB - P37840) with a silent mutagenesis of codon 136 (TAC to TAT)

  Transfected construct (pNatB)           pNatB                      ([@bib41])                      <http://www.addgene.org/53613/>                           Expression of the fission yeast NatB complex - chloramphenicol marker

  Chemical compound, drug                 DEAE sepharose fast flow   GE Healthcare, \#17-0709-01                                                               

  Other                                   Copper/carbon grids        <https://www.quantifoil.com/>   R 2/2 grids                                               

  Software, algorithm                     UCSF Chimera               ([@bib67])                      <https://www.cgl.ucsf.edu/chimera>                        RRID:[SCR_004097](https://scicrunch.org/resolver/SCR_004097)

  Software, algorithm                     SerialEM                   ([@bib55])                      <https://bio3d.colorado.edu/SerialEM/>                    RRID:[SCR_017293](https://scicrunch.org/resolver/SCR_017293)

  Software, algorithm                     FOCUS                      ([@bib4])                       <http://focus-em.org>                                     

  Software, algorithm                     MotionCor2                 ([@bib91])                      <https://emcore.ucsf.edu/ucsf-motioncor2>                 RRID:[SCR_016499](https://scicrunch.org/resolver/SCR_016499)

  Software, algorithm                     RELION 2, 3                ([@bib74];\                     <http://www2.mrc-lmb.cam.ac.uk/relion>                    RRID:[SCR_016274](https://scicrunch.org/resolver/SCR_016274)
                                                                     [@bib92])                                                                                 

  Software, algorithm                     COOT                       ([@bib18])                      <https://www2.mrc-lmb.cam.ac.uk/personal/pemsley/coot/>   RRID:[SCR_014222](https://scicrunch.org/resolver/SCR_014222)

  Software, algorithm                     Molprobity                 ([@bib88])                      <http://molprobity.biochem.duke.edu>                      RRID:[SCR_014226](https://scicrunch.org/resolver/SCR_014226)
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

α-Syn expression and purification {#s3-1}
---------------------------------

The fibrillary polymorph of WT full length unmodified α-Syn polymorph 2a and 2b were assembled from monomeric α-Syn expressed and purified as described in [@bib5] and [@bib26]. Briefly recombinant, wild-type α-Syn was expressed in *E. coli* strain BL21(DE3), transformed with the expression vector pET3a (Novagen) encoding wild-type, full-length α-Syn. Expression was induced by 0.5 mM IPTG for 2 hr, when the bacteria grown in LB medium at 37°C had reached an optical density of 1.0 at 660 nm. Soluble, monomeric α-Syn was purified from the bacterial lysate as previously described ([@bib30]). α-Syn concentration was determined spectrophotometrically using an extinction coefficient of 5960 M^−1^\*cm^−1^ at 280 nm. Pure α-Syn (0.7 mM) in 50 mM Tris-HCl, pH 7.5, 150 mM KCl was filtered through sterile 0.22 μm filters and stored at −80°C.

For preparation of fibrils carrying post-translationally modifications, full-length α-Syn was expressed in competent *Escherichia coli* BL21(DE3) (Stratagene, La Jolla, CA, USA) from the pRT21 expression vector. To acetylate the N-terminus, cells were pre-transfected by pNatB vector coding for the N-terminal acetylase complex (plasmid kindly provided by Daniel Mulvihill, School of Biosciences, University of Kent, Canterbury, UK) ([@bib41]). The various α-Syn forms were purified by periplasmic lysis, ion exchange chromatography, ammonium sulfate precipitation, and gel filtration chromatography as previously described ([@bib33]; [@bib37]; [@bib52]). Purified α-Syn was phosphorylated using polo like kinase 2 (PLK2) expressed in *E. coli* BL21-DE3-pLysS, and isolated via its His-tag. Phosphorylated from non-phosphorylated α-Syn was then separated using standard ion exchange and gel filtration chromatography. N-terminally acetylated and phosphorylated α-Syn strains were cleared from endotoxins using one run of Detoxi-Gel Endotoxin Removing Gel (Thermo Scientific) or until endotoxins were below detection level. Protein sequences were verified by tryptic digestion and MALDI mass spectrometry (MS). Alternatively, HPLC/ESI tandem MS was performed to determine total mass. Coomassie blue or silver staining of the SDS PAGE gel and analytical ultracentrifugation were used to determine purity and monodispersity. Protein concentration was measured using the bicinchoninic acid (BCA) assay (Thermo Scientific) with bovine serum albumin as a standard. Purified α-Syn was dialyzed in a 2 kDa Slide-A-Lyzer unit (Thermo Scientific, for max. 3 ml) against HPLC-water (VWR). Aliquots (500 µg) were dispensed into 1.5 ml tubes, frozen on dry ice, and lyophilized for 2 hr in an Eppendorf concentrator (Eppendorf) and stored at −80°C until use.

Disease-linked E46K mutant α-Syn was expressed and purified using a periplasmic purification protocol as described earlier ([@bib6]; [@bib37]). Briefly, plasmid pRK172 was co-expressed with N-terminal acetyltransferase B (NatB) complex as described earlier ([@bib41]). Colonies containing both plasmids (NatB and pRK172) were selected using two different antibiotics and grown in 1 liter of lysogeny broth at 37°C. After reaching an optical density of 1.0 at 600 nm, expression was induced with 1 mM IPTG for 5 hr. Cells were harvested and α-Syn collected from the periplasmic space of the cells, using osmotic shock methods described earlier ([@bib37]). Protein was further purified using ion exchange chromatography and hydrophobic interaction chromatography ([@bib6]).

Fibrillization {#s3-2}
--------------

Full-length, wildtype unmodified α-Syn was incubated at 37°C for one week under continuous shaking in an Eppendorf Thermomixer set at 600 r.p.m., to assemble into fibrillar form. 700 μM α-Syn was assembled in 50 mM Tris-HCl, pH 7.5, 150 mM KCl buffer ([Table 1](#table1){ref-type="table"}).

To prepare fibrils of full-length, phosphorylated, N-terminally acetylated, N-terminally acetylated and the E46K mutant α-Syn, recombinant protein (dialyzed and lyophilized) was diluted to 5 mg/mL in 200 µL of Dulbecco's phosphate buffered saline (DPBS) buffer (Gibco; 2.66 mM KCL, 1.47 mM KH~2~PO~4~, 137.93 mM NaCl, 8.06 mM Na~2~HPO~4~-7H~2~O pH 7.0--7.3). After 5 days of incubation at 37°C with constant agitation (1,000 rpm) in an orbital mixer (Eppendorf), reactions were sonicated for 5 min in a Branson 2510 water bath, aliquoted, and stored at −80°C. All fibrils were created in the presence of an air-water interface. The presence of amyloid fibrils was confirmed by thioflavin T fluorimetry and high molecular weight assemblies were visualized by gel electrophoresis.

Electron microscopy {#s3-3}
-------------------

Cryo-EM grids were prepared using a Leica EM GP automatic plunge freezer (Leica Microsystems) with 80% humidity at 20°C. 3 µL aliquots were applied onto 60 s glow-discharged, 300 mesh, copper Quantifoil grids (R2/1). After blotting, grids were plunge frozen in liquid ethane cooled by liquid nitrogen.

Micrographs were acquired on a Titan Krios (ThermoFisher Scientific) transmission electron microscope, operated at 300 kV and equipped with a Gatan Quantum-LS imaging energy filter (GIF, 20 eV zero loss energy window; Gatan Inc). Images were recorded on a K2 Summit electron counting direct detection camera (Gatan Inc) in dose fractionation mode (50 frames) using the Serial EM software ([@bib55]) at pixel sizes of 0.831 Å or 0.629 Å, and a total dose of \~69 electrons per square Angstrom (e^-^/Å^2^) for each micrograph. Micrographs were processed and analyzed during data collection with FOCUS ([@bib4]), applying drift-correction and dose-weighting using MotionCor2 ([@bib91]). Specific data collection parameters for the various datasets are detailed in [Table 2](#table2){ref-type="table"}.

Image processing {#s3-4}
----------------

Computer image processing and helical reconstruction was carried out with RELION 2.1 ([@bib74]) and RELION 3.0 ß ([@bib92]), using the methods described in [@bib91]. Filament selection per micrograph was done manually in RELION 2.1. Segments were extracted with a box size of 280 pixels and an inter-box distance of 28 pixels. A summary of the number of micrographs and segments that went into the various steps of processing are presented in [Table 2](#table2){ref-type="table"}. After 2D classification with a regularization value of T = 2, 2D class averages with a visible separation of individual rungs were selected for further processing. For class averages formed by segments from polymorph 2, the calculated power spectra showed a meridional peak intensity (Bessel order n = 0) at the layer line of 1/ (4.8 Å). For polymorph 2b, power spectra showed peak intensities on both sides of the meridian (Bessel order n = 1). This is the result of an approximate 2~1~ screw symmetry between α-Syn subunits on the two protofilaments ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The best 2D classes were selected for a round of 3D classification with T = 8 and optimization of the helical twist and rise using a *helical_z\_percentage* parameter ([@bib35]) of 10%. A cylinder generated via the helix toolbox tool was used as initial model. This resulted in three classes where ß-sheets perpendicular to the fibril axis were clearly separated. Segments contributing to classes 1 and 2, which corresponded to α-Syn polymorphs 2a and 2b, respectively, were then processed separately. The 3D maps from their respective classes were used as initial models after applying a low-pass filter to 30 Å. Then, a 3D classification with a single class (K = 1) and T = 20, which has allowed the successful reconstruction of amyloid filaments, was carried out ([@bib19]; [@bib22]; [@bib33]).

The 3D auto-refine procedure in RELION 3.0, with optimization of helical twist and rise, resulted in structures with overall resolutions of 3.34 Å (α-Syn polymorph 2a) and 3.75 Å (α-Syn polymorph 2b). Post-processing with soft-edge masks and estimated map sharpening *B*-factors of −67.1 and −76.4 Å^2^, respectively, gave maps with resolutions of 3.0 Å (α-Syn polymorph 2a) and 3.4 Å (α-Syn polymorph 2b) (by the FSC 0.143 criterion). Local resolution values and local-resolution-filtered maps were obtained in RELION 3.0. ([Table 2](#table2){ref-type="table"}, [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

Model building and refinement {#s3-5}
-----------------------------

A model for the α-Syn polymorph 2a fibril was built into the RELION local resolution-filtered map with COOT ([@bib18]), by conserving as many secondary structure elements as possible from our previous α-Syn polymorph one model (PDB ID 6h6b) ([@bib33]), together with the use of secondary structure information derived from ssNMRs, which served as an initial model. The structure was then refined against the same map with PHENIX real space refine ([@bib1]) using rotamer and Ramachandran restraints, and non-crystallographic symmetry and beta strand geometry constraints. The building and refinement of the α-Syn polymorph 2b model was more challenging due to the lower resolution of the map. An initial structure was built into the α-Syn polymorph 2b local resolution-filtered map by fitting of the α-Syn polymorph 2a model using COOT. To successfully refine the structure, it was necessary to generate secondary structure restraints in Phenix, based on CA backbone and intermolecular beta sheets to refine the structure. All structures were validated using Molprobity ([@bib88]). Figures were prepared using UCSF Chimera ([@bib67]).

NMR spectroscopy {#s3-6}
----------------

NMR spectra were recorded at 20.0 T static magnetic field using 3.2 mm rotors and a triple-resonance probe. The reproducibility of the sample preparation was previously verified with 20 ms DARR fingerprint spectra ([@bib26]). The secondary chemical-shift analysis was based on the sequential assignments (BMRB accession code 18860) and was presented before ([@bib26]; [@bib27]). The PAR spectrum ([@bib14]; [@bib44]) was recorded using a mixing time of 8 ms. The assignments for the S87/A17-19 cross peaks are unambiguous within a range of 0.15 ppm, corresponding to about ½ of the ^13^C line width. Assignments of restraints given for reference on the full aliphatic region of the PAR spectrum in the [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} are mostly ambiguous, which prevented structure determination by NMR. Ambiguities were lifted by comparison to the here determined cryo-EM structure.

Data availability {#s3-7}
-----------------

Raw cryo-EM micrographs are available in EMPIAR, entry numbers EMPIAR-10323. The 3D maps are available in the EMDB, entry numbers EMD-10307 (α-Syn polymorph 2a) and EMD-10305 (α-Syn-polymorph 2b). Atomic coordinates are available at the PDB with entry numbers PDB 6SSX (α-Syn polymorph 2a) and PDB 6SST (α-Syn polymorph 2b).
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This paper describes two new polymorphs of in vitro assembled α-synuclein filaments. The new polymorphs termed 2a and 2b were generated under different growth conditions in comparison to previously determined polymorphs 1. Most surprisingly, the polymorphs of group 2 fold into bent β-arches conformation of similar outline of polypeptide path but involving different segments of the structure combined into the β-arch fold. Although the two polymorphs of group 2 share the same core structure, they differ in their relative arrangement. Although the disease-relevance of the new structures is unclear, these results help exploring the conformational variability in α-synuclein amyloid filaments, and the discussion on how different in-vitro aggregation conditions might lead to different polymorphs was considered useful.

**Decision letter after peer review:**

Thank you for submitting your article \"Two new polymorphic structures of α-synuclein solved by cryo-electron microscopy\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, including Sjors HW Scheres as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by John Kuriyan as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The reviewers had an extended discussion whether this manuscript is suitable for publication in *eLife*. On the one hand, the disease-relevance of the new structures is unclear; on the other hand, these results help exploring the conformational variability in α-synuclein amyloid filaments. However, it was felt that potentially the most significant contribution of this manuscript is the discussion on how different in-vitro aggregation conditions might lead to different polymorphs. The paper is well written, but the points below need to be addressed before publication.

Essential revisions:

1\) It would be good if the authors could extend on their rationale how different in-vitro aggregation conditions might lead to different polymorphs. For example, could they make predictions whether new, unseen conditions would lead to polymorphs of type 1 or 2? For example, by testing different (poly)anions? At the very least, (the feasibility of) such ideas should be discussed. However, if such predictions could even be tested experimentally, then this would further strengthen the paper. (This would not necessarily require cryo-EM reconstructions; possibly (2D class averages of) negative stain images would suffice.)

2\) The authors mention two-fold and approximate 2_1 screw symmetry for the two polymorphs. However, these symmetries do not seem to have been applied to the maps. This should be rectified. Also, there seem to be main-chain breaks between Ala69 and Val70 in both structures. This cannot be due to conformational heterogeneity, as the entire neighbourhood of these residues is very well ordered. Therefore, these are probably the results of local minima in the helical refinement. This needs to be resolved; hopefully applying the correct symmetry will help. It would help the reviewing process if the authors could submit unfiltered and unmasked half-maps with their revision. Also, hopefully in the new maps the observation that C-terminal density is interpreted with side chains (90-95) when no side chain is clearly visible will be no longer relevant. If it does remain relevant, side chains should be removed from the model.

3\) The 2a map contains more detail to justify accurate model building than the 2b map. Therefore, the authors should detail their strategy of model building for map 2b more clearly if their model building was primarily based on map 2a. In this context, it is not clear how the described differences are due to the low resolution or represent true structural differences. In the two polymorphs, the authors claim that they have an identical fold. Inspecting the atomic models, it is clear that the secondary structure assignments of β-sheets from the two polymorphs are not identical. Based on the Materials and methods statement: \"To successfully refine the structure, it was necessary to generate secondary structure restraints to refine the structure using.\", it would be illuminating to detail the restraints more explicitly and why the refinement of model 2b resulted in a more relaxed conformation with less β-sheet content. Possibly, it could be more appropriate to restrain them more strongly in model 2b due to lower resolution. In addition, the different chains within a PDB file are not identical. During the refinement, all chains need to be symmetry restrained to yield the same conformation. This could have been a consequence of the non-imposed symmetry on the map, but it should be resolved.

4\) A rise of nearly 5A seems too high for energetically stable β-sheet formation. Is the pixel size correct? The authors should provide convincing evidence for absolute pixel calibration, or in the absence of such evidence, re-scale the pixel to the expected rise of 4.7-8A.

5\) Are the authors convinced the handedness of their structure is correct? What was it based on?

6\) Given the disease relevance of the results is uncertain, it would be good to focus the Introduction more on synucleinopathies in general, as opposed to the current focus on Parkinson\'s disease (PD). Since this study elaborates on the structural polymorphism of assembled α-synuclein, the clinical heterogeneity of synucleinopathies should be emphasised more. In addition, at least human brain-derived filaments from PD should be mentioned and their morphological similarities/differences to the in vitro assembled polymorphs discovered to date should be explained (e.g. R.A. Crowther et al., 2000).

7\) Figure 3 contains too low resolution maps to convincingly make the point that these structures adopt the same main chain trace as the polymorph 2a. Especially Figure 3B and 3C look very artefactual. Perhaps X-Y slices could be used, otherwise these reconstructions should be removed from the paper. If the authors are keen to keep these results in, the reconstructed maps should be submitted alongside the revision so that a better informed decision can be made.

10.7554/eLife.48907.sa2

Author response

> Essential revisions:
>
> 1\) It would be good if the authors could extend on their rationale how different in-vitro aggregation conditions might lead to different polymorphs. For example, could they make predictions whether new, unseen conditions would lead to polymorphs of type 1 or 2? For example, by testing different (poly)anions? At the very least, (the feasibility of) such ideas should be discussed. However, if such predictions could even be tested experimentally, then this would further strengthen the paper. (This would not necessarily require cryo-EM reconstructions; possibly (2D class averages of) negative stain images would suffice.)

The use of polyanions has been widely described by Fink and Uversky for over two decades. They showed that assembly conditions and additives lead to different kinetics and morphologies. However, their work with poly-anions was not intended to obtain non-polymorphic samples suitable for structural studies (cryo EM, NMR, X-ray). Instead, we screened for α synuclein assembly conditions that would produce a single fold of a-syn fibrils, suitable for structure-function investigations.

Indeed, we did identify assembly conditions of WT human α synuclein leading to distinct and yet undetermined α synuclein amyloid folds (Bousset et al., 2013; Makky et al., 2016; Verasdonck et al., 2016). In this work, the ribbon polymorph displayed a radically different distribution of the β strands along the synuclein sequence and lacked a defined helical repeat, not seen in any published structure of α synuclein. Polymorph fibril 91 showed at least a new quaternary fold with a helical assembly of protofilaments with an apparent width of more than 50nm.

Trying to provide a rationale for amyloid folding would be, in our view, even more challenging than trying to explain protein folding of globular protein. The interplay between intramolecular folding on one side, and templating by intermolecular interactions on the other side, is still poorly understood. We prefer not to speculate on mechanisms governing amyloid folding. With that said, a large scale project to investigate the formation of α-synuclein fibrils under different in-vitro aggregation conditions is indeed an interesting idea, but one that would require time and effort, which is outside the scope of our study.

> 2\) The authors mention two-fold and approximate 2_1 screw symmetry for the two polymorphs. However, these symmetries do not seem to have been applied to the maps. This should be rectified. Also, there seem to be main-chain breaks between Ala69 and Val70 in both structures. This cannot be due to conformational heterogeneity, as the entire neighbourhood of these residues is very well ordered. Therefore, these are probably the results of local minima in the helical refinement. This needs to be resolved; hopefully applying the correct symmetry will help. It would help the reviewing process if the authors could submit unfiltered and unmasked half-maps with their revision. Also, hopefully in the new maps the observation that C-terminal density is interpreted with side chains (90-95) when no side chain is clearly visible will be no longer relevant. If it does remain relevant, side chains should be removed from the model.

We thank the reviewers for these constructive comments. We have re-processed the maps, applying the approximate 2_1 screw symmetry. Polymorph 2a was solved with a helical rise of 4.8Å and a helical twist of -0.8°. Polymorph 2b has a helical rise of 2.4Å and a helical twist of 179.6°. After reprocessing the data with the correct symmetry applied, the main-chain break between Ala69 and Val70 was resolved. Both unfiltered and unmasked half-maps are submitted with this revision.

> 3\) The 2a map contains more detail to justify accurate model building than the 2b map. Therefore, the authors should detail their strategy of model building for map 2b more clearly if their model building was primarily based on map 2a. In this context, it is not clear how the described differences are due to the low resolution or represent true structural differences. In the two polymorphs, the authors claim that they have an identical fold. Inspecting the atomic models, it is clear that the secondary structure assignments of β-sheets from the two polymorphs are not identical. Based on the Materials and methods statement: \"To successfully refine the structure, it was necessary to generate secondary structure restraints to refine the structure using.\", it would be illuminating to detail the restraints more explicitly and why the refinement of model 2b resulted in a more relaxed conformation with less β-sheet content. Possibly, it could be more appropriate to restrain them more strongly in model 2b due to lower resolution. In addition, the different chains within a PDB file are not identical. During the refinement, all chains need to be symmetry restrained to yield the same conformation. This could have been a consequence of the non-imposed symmetry on the map, but it should be resolved.

The lower resolution of the map for polymorph 2b impacts the quality of the model, the missing interaction between the two protofilaments around residues 57 also reveals the flexibility of this loop. The model for polymorph 2b was built by starting with the polymorph 2a model, and inspecting the backbone in the 2b density map. The lower resolution of the 2b map leads to weaker restrains during refinement, therefore we imposed intermolecular hydrogen bonds during the refinement (using the "SHEET atom 1 \-\-- Atom 2" command in the PDB header, with visually identified H-bonds, Phenix refinement procedure allocate restrain for all H bonds that are closer than 2.9A apart).

The 10 chains within the PDB were not restrained due to the fact that the map is not of the same quality along fibril axis, and the two protofilaments were not restrained either. The reason for this is that the masking procedure leads to maps of lower quality at the edges of the mask, and that we need multiple layers to refine the intermolecular hydrogen bonds that run parallel to the fibril axis.

We can impose a symmetry or dock polymorph 2a structure, but this would erase minor differences that we can detect if symmetry averaging or restrain are not imposed.

> 4\) A rise of nearly 5A seems too high for energetically stable β-sheet formation. Is the pixel size correct? The authors should provide convincing evidence for absolute pixel calibration, or in the absence of such evidence, re-scale the pixel to the expected rise of 4.7-8A.

We thank the reviewers for this recommendation. We have verified and corrected the pixel size to calibrated values. It now is 0.629 Å. The corrected maps now have a rise of 4.8Å for polymorph 2a and 2.4Å for polymorph 2b.

> 5\) Are the authors convinced the handedness of their structure is correct? What was it based on?

The handedness was analyzed by AFM imaging, as also done previously (Guerrero-Ferreira et al., 2018).

> 6\) Given the disease relevance of the results is uncertain, it would be good to focus the Introduction more on synucleinopathies in general, as opposed to the current focus on Parkinson\'s disease (PD). Since this study elaborates on the structural polymorphism of assembled α-synuclein, the clinical heterogeneity of synucleinopathies should be emphasised more. In addition, at least human brain-derived filaments from PD should be mentioned and their morphological similarities/differences to the in vitro assembled polymorphs discovered to date should be explained (e.g. R.A. Crowther et al., 2000).

Thank you for this suggestion. We have modified the Introduction accordingly to recognize previous morphological characterization of α-synuclein fibrils.

> 7\) Figure 3 contains too low resolution maps to convincingly make the point that these structures adopt the same main chain trace as the polymorph 2a. Especially Figure 3B and 3C look very artefactual. Perhaps X-Y slices could be used, otherwise these reconstructions should be removed from the paper. If the authors are keen to keep these results in, the reconstructed maps should be submitted alongside the revision so that a better informed decision can be made.

We thank the reviewers for these comments, and have replaced Figure 3 with 2d projections of the filament cross-sections.

[^1]: Robert P Apkarian Integrated Electron Microscopy Core, Emory University School of Medicine, Atlanta, United States.
